glp-1/gip vs tirzepatide Frontiers Bumps and humps in the

It makes sense to think of gas, bloating, constipation, and other digestive health problems here, because after all, we are talking about the gut

Wegovy (semaglutide) oral tablet is indicated for weight loss and long-term weight maintenance, as well as to reduce the risk of major adverse cardiovascular events such as death, heart attack, or stroke in adults with established cardiovascular disease and either obesity or overweight

In addition, as semaglutide is not officially approved for chronic weight management, changes in facial appearance are not listed in the FDA label as adverse events [88]

They should not be interpreted as guaranteed or typical outcomes for every patient

Two practical implications follow